相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass
Harry K. Genant et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Romosozumab Improves Bone Mass and Strength While Maintaining Bone Quality in Ovariectomized Cynomolgus Monkeys
Michael S. Ominsky et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Kinetic reconstruction reveals time-dependent effects of romosozumab on bone formation and osteoblast function in vertebral cancellous and cortical bone in cynomolgus monkeys
Rogely Waite Boyce et al.
BONE (2017)
Romosozumab Treatment Converts Trabecular Rods into Trabecular Plates in Male Cynomolgus Monkeys
Jonathan B. Matheny et al.
CALCIFIED TISSUE INTERNATIONAL (2017)
Sclerostin deficiency in humans
Antoon H. van Lierop et al.
BONE (2017)
Sclerostin expression in the subchondral bone of patients with knee osteoarthritis
Long Wu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
Preventing painful age-related bone fractures: Anti-sclerostin therapy builds cortical bone and increases the proliferation of osteogenic cells in the periosteum of the geriatric mouse femur
Michelle L. Thompson et al.
MOLECULAR PAIN (2016)
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
F. Cosman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Postmenopausal Osteoporosis
Dennis M. Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Carcinogenicity risk assessment of romosozumab: A review of scientific weight-of-evidence and findings in a rat lifetime pharmacology study
Luc Chouinard et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2016)
Sclerostin inhibition promotes TNF-dependent inflammatory joint destruction
Corinna Wehmeyer et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Administration of romosozumab improves vertebral trabecular and cortical bone as assessed with quantitative computed tomography and finite element analysis
Christian Graeff et al.
BONE (2015)
The Effect of Discontinuing Treatment With Blosozumab: Follow-up Results of a Phase 2 Randomized Clinical Trial in Postmenopausal Women With Low Bone Mineral Density
Christopher P. Recknor et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density
Robert R. Recker et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Loss of sclerostin promotes osteoarthritis in mice via β-catenin-dependent and -independent Wnt pathways
Wafa Bouaziz et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Sclerostin Deficiency Is Linked to Altered Bone Composition
Norbert Hassler et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Geographic and ethnic disparities in osteoporotic fractures
Jane A. Cauley et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
Michael R. McClung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Role of sclerostin in bone and cartilage and its potential as a therapeutic target in bone diseases
E. Michael Lewiecki
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2014)
Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday
Michael McClung et al.
AMERICAN JOURNAL OF MEDICINE (2013)
Increased Bone Formation and Bone Mass Induced by Sclerostin Antibody Is Not Affected by Pretreatment or Cotreatment with Alendronate in Osteopenic, Ovariectomized Rats
Xiaodong Li et al.
ENDOCRINOLOGY (2011)
Single-Dose, Placebo-Controlled, Randomized Study of AMG 785, a Sclerostin Monoclonal Antibody
Desmond Padhi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
分享论文
